The European Medicines Agency (EMA) on Friday recommended the introduction of anti-Corona virus vaccines developed by Pfizer and BioNotech to children between 12 and 15 years old. This decision is opening the way for the first time in the continent to vaccinate children during the epidemic.
The head of the vaccine-reviewing EMA, Marco Cavalieri, said the EU regulator had obtained the necessary figures to approve the use of the vaccine for children and adolescents and found it to be highly effective against Covid-19.
He said that the decision needs to be approved by the European Commission and the regulators of different countries. Earlier, regulators in Canada and the US had taken a similar decision last month. Developed countries are working towards getting more and more of their population vaccinated.
The Pfizer-BioNtech vaccine was first approved in the European Union of 27 countries and was licensed in December for the introduction of people 16 years or older.
The EMA’s recommendation to approve vaccination for children is based on studies in more than 2,000 adolescents in the US. The study found the vaccine to be safe and effective. Researchers will monitor the long-term safety of vaccine doses for the next two years in children.